Treffer: Key aspects of analyzing microarray gene-expression data.

Title:
Key aspects of analyzing microarray gene-expression data.
Authors:
Chen JJ; US FDA, Division of Personalized Nutrition and Medicine, National Center for Toxicological Research, Jefferson, AR 72079, USA. jamesj.chen@fda.hhs.gov
Source:
Pharmacogenomics [Pharmacogenomics] 2007 May; Vol. 8 (5), pp. 473-82.
Publication Type:
Journal Article; Review
Language:
English
Journal Info:
Publisher: Taylor & Francis Country of Publication: England NLM ID: 100897350 Publication Model: Print Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE
Imprint Name(s):
Publication: 2024- : [Milton Park, Oxfordshire] : Taylor & Francis
Original Publication: London : Ashley Publications,
Number of References:
60
Entry Date(s):
Date Created: 20070501 Date Completed: 20071210 Latest Revision: 20070430
Update Code:
20250114
DOI:
10.2217/14622416.8.5.473
PMID:
17465711
Database:
MEDLINE

Weitere Informationen

One major challenge with the use of microarray technology is the analysis of massive amounts of gene-expression data for various applications. This review addresses the key aspects of the microarray gene-expression data analysis for the two most common objectives: class comparison and class prediction. Class comparison mainly aims to select which genes are differentially expressed across experimental conditions. Gene selection is separated into two steps: gene ranking and assigning a significance level. Class prediction uses expression profiling analysis to develop a prediction model for patient selection, diagnostic prediction or prognostic classification. Development of a prediction model involves two components: model building and performance assessment. It also describes two additional data analysis methods: gene-class testing and multiple ordering criteria.